Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. Our clinically-proven, AI-based digital care platform works with coronary computed tomography angiography (CCTA) imaging to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum.
We measure atherosclerosis – plaque build-up in the heart’s arteries – not indirect markers such as risk factors and symptoms of disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease evaluation and reporting that’s tailored to each stakeholder, improving overall clinical and financial outcomes.
Who should do the cleerly test?
- History of Cardiovascular disease
- High cholesterol
- Family history of cardiovascular disease
- High Ct calcium score
- Symptoms of Shortness of breath or fatigue
- General health prevention
Take a look at the clinical evidence:
https://cleerlyhealth.com/clinical-evidence
- 50% of people who suffer a heart attack will do so without experiencing symptoms.1
- 70% of heart attack victims are considered low risk by traditional methods of assessing heart disease.2
- 75% of lesions that are responsible for heart attacks only cause mild narrowing of the arteries and are missed by conventional stress testing.3
- Rapid reporting of your non-invasive CCTA with <1 hour turnaround times available 24 hours/day.
